Jinxin Fertility Group Limited (abbrev. JXR) disclosed that it repurchased 4.30 million ordinary shares on 29 May 2026 via on-market transactions. The shares were bought at prices between HK$2.24 and HK$2.26, for a total consideration of HK$9.67 million.

Including this latest transaction, JXR has bought back 86.61 million shares since the current repurchase mandate was approved on 26 June 2025. The cumulative volume represents 3.16% of the company’s issued share capital on the mandate date, against an authorisation limit of 274.47 million shares.

As of 29 May 2026, JXR’s issued share capital stood at 2.71 billion shares. A total of 46.95 million repurchased shares—around 1.74% of the outstanding share base—are awaiting formal cancellation; hence, the issued share figure has not yet been reduced.

In accordance with Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or transferring any treasury shares until 28 June 2026.